How to choose a healthtech accelerator

Healthtech accelerators sell the same thing in very different packages. Some invest cash and take equity. Some take nothing and pay you in awards. Some charge a fee. The question is never which model is best in the abstract. It is whether the specific help behind the check moves the three things a health company actually needs: clinical validation, regulatory progress, and access to the people who buy. This guide gives you a way to read the offers.

What healthtech founders actually need from a program

Health companies die differently than other startups. Three needs dominate.

• Clinical validation. You need evidence that the product works in a real care setting, which means access to clinicians, patients, and sometimes lab space. A program attached to a health system can shorten this by months.
• Regulatory navigation. If your product touches FDA territory or handles clinical data, you need people who have filed before, not a webinar about filing.
• Payer and provider access. Selling into health systems and payers is its own craft. Introductions that reach a decision maker are worth more than any curriculum.

Rank these for your company first. Then read every program against your ranking.

Reading the equity against the specific help

The equity programs in this vertical cluster around a few models, and the partner behind each one is the real product.

Three Techstars healthcare programs invest 220,000 dollars for a minimum of 5 percent, each anchored by a hospital system: Johns Hopkins and CareFirst in Baltimore, Northwestern Medicine in Chicago, and Permanente Medicine in Washington, DC. The structure is 20,000 dollars for 5 percent in common stock plus a 200,000 dollar uncapped post-money SAFEiA Simple Agreement for Future Equity: money now that converts into shares later, not a loan. with an MFN clauseiMost Favored Nation: lets an earlier investor upgrade to the best terms you later give anyone else.. Health Wildcatters in Dallas invests 30,000 dollars for 8 percent. AlphaLab Health invests up to 100,000 dollars through an uncapped SAFE plus 3 percent common equity, and its partnership with Allegheny Health Network includes lab space at Allegheny General Hospital's campus.

The comparison to run: does the partner deliver the thing you ranked first? A hospital network that will host your pilot can justify a 5 percent check. The same check without that access is just expensive money.

The round below is a hypothetical, used only to show the mechanics.

• At signing: 20,000 dollars buys 5 percent in common stock. The 200,000 dollar SAFE is uncapped and has not converted yet.
• Later, a priced round values the company at 10,000,000 dollars post-money. The uncapped SAFE converts at that price: 200,000 divided by 10,000,000 is 2 percent.
• Total ownership from the accelerator is now roughly 7 percent, and the MFN clause means a lower cap granted to anyone else before then could push it higher.

The headline "5 percent" is a floor, not the whole cost. Model the SAFE at a realistic next-round valuation before you compare programs. Our SAFE guide walks the mechanics in full.

Not every strong program takes equity. MedTech Innovator takes no equity and charges no fee, and early-stage companies compete for up to 500,000 dollars in non-dilutive awards while working with corporate partner mentors. At the other end, some programs are fee-based: Project Healthcare in Nashville costs 6,000 dollars to participate, and MATTER in Chicago is a membership running from 0 to 400 dollars a month depending on tier. A fee model is not automatically worse. It just means you are a customer, and you should evaluate it like one.

Questions to ask before you apply

Ask these of the program, and of its alumni, before you sign anything.

• Is the follow-on real? Ask which recent portfolio companies received follow-on investment from the program or its partners, and verify with the founders.
• Is pilot access contractual or aspirational? "Access to our health system" can mean a signed pilot pathway or a hallway introduction. Ask how many cohort companies ran an actual pilot with the partner, and what the pathway looked like.
• Is the regulatory support real versus advertised? Ask who specifically advises on regulatory strategy, what their filing experience is, and how many hours you get. A named person with FDA submissions behind them is support. A mentor list is not.
• Who is the partner's champion? Hospital partnerships work when a named clinical or innovation leader owns the relationship. Ask who that person is and meet them.

The live directory of healthtech programs

Here are the verified healthtech and medtech programs we currently list. Terms, windows, and confidence badges are live, and each links to its full page.

The full vertical page lives at /accelerators/healthtech_medtech, and you can line programs up side by side on the compare page.

FAQ

Is a hospital-affiliated accelerator always better for a clinical product?

No, but it is better when your bottleneck is validation or pilots. If your bottleneck is capital or engineering, the affiliation matters less than the check and the network.

Are equity-free programs like MedTech Innovator too good to be true?

They are real, but the model is competitive awards rather than a guaranteed check. MedTech Innovator pairs companies with corporate mentors and awards up to 500,000 dollars across its program, and not every company receives an award.

Should I avoid fee-based programs entirely?

Not necessarily. A 6,000 dollar fee is far cheaper than 5 percent of a company that succeeds. The test is whether the curriculum and introductions are worth the price in cash, judged the way you would judge any vendor.

Healthtech application windows move on their own calendars. Get an alert when a program on your shortlist opens.

Get HealthTech & MedTech deadline alerts

One digest a week. Deadline alerts only for verticals you pick. Unsubscribe anytime.

Email addressNotify me

This is general education, not legal or investment advice. Read the actual documents and talk to a lawyer before you sign.